NORTH KINGSTOWN, R.I. and BOSTON, Dec. 20, 2010 /PRNewswire/ -- Riverside Partners, a Boston-based private equity firm, is pleased to announce that it has made a majority equity investment in Dominion Diagnostics ("Dominion"), a leading laboratory services company focused on quantitative testing to support patient medication monitoring. The investment was completed in partnership with the founders and management of the business.
Founded in 1997, Dominion is a premier provider of comprehensive clinical quantitative urine drug testing, medication monitoring, and support services nationwide. For the past 13 years, Dominion has provided laboratory services to thousands of clients in a variety of medical specialties, including Addiction Treatment, Behavioral Health, Pain Medicine, Primary Care, Psychiatry and Hospital Systems.
"When we decided to bring on a financial partner for Dominion, we focused on finding a private equity firm with significant health care expertise as well as experience working with founder-owned companies. We are extremely excited about our partnership with Riverside Partners and believe that together we will continue to help clinicians and patients and improve clinical outcomes," said Dr. Frank Fornari, Founder of Dominion Diagnostics.
Passages Malibu Center
Food Bags